info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

US Drug Delivery Devices Market Research Report Information By Route of Administration (Oral, Ocular, Inhalation, Nasal, Injectable, Topical, and Others), By Application (Cardiovascular, Diabetes, Cancer, Infectious Diseases, and Others), By End User (Hospitals, Ambulatory Services, and Home Healthcare), and By Region (North America, Europe, Asia-Pacific, and Rest Of The World) – Market Forecast Till 2032


ID: MRFR/HC/11870-CR | 100 Pages | Author: Garvit Vyas| December 2023

The demand for injectable drug delivery devices in the United States is experiencing robust growth, driven by various factors that underscore the importance of these devices in modern healthcare practices. Injectable drug delivery devices have become integral components in the administration of therapeutic drugs, providing precise and efficient means of delivering medications to patients. One of the key drivers of the increasing demand for injectable drug delivery devices is the rising prevalence of chronic diseases in the United States. Conditions such as diabetes, autoimmune disorders, and various cancers often require regular and controlled drug administration. Injectable devices offer a reliable method for delivering medications with accuracy, ensuring that patients receive the prescribed dosage to effectively manage their conditions. Moreover, the aging population in the United States contributes significantly to the demand for injectable drug delivery devices. As the population ages, there is a greater incidence of chronic diseases and conditions that necessitate ongoing medical treatment. Injectable devices play a crucial role in the daily lives of many elderly individuals who rely on these devices for self-administration of medications, particularly for conditions like diabetes and osteoporosis. Advancements in biotechnology and the development of new biologic drugs have further fueled the demand for injectable drug delivery devices. Many of these biologic medications, including monoclonal antibodies and growth factors, require specialized delivery methods to ensure their effectiveness. Injectable devices provide a controlled and targeted approach for delivering these complex therapeutic agents, contributing to the expansion of the market. The convenience and patient-friendly nature of injectable drug delivery devices also contribute to their increasing demand. Devices such as autoinjectors and pre-filled syringes offer a user-friendly experience, allowing patients to self-administer medications in the comfort of their homes. This not only enhances patient compliance but also reduces the burden on healthcare facilities. Additionally, the COVID-19 pandemic has underscored the significance of injectable drug delivery devices, particularly in the context of vaccine administration. The mass vaccination campaigns necessitated efficient and precise delivery of vaccines, and injectable devices played a pivotal role in ensuring the success of these efforts. The pharmaceutical and healthcare industries in the United States continue to invest in research and development to enhance the capabilities of injectable drug delivery devices. This commitment to innovation contributes to the sustained growth of the market as new and improved devices are introduced, offering healthcare providers and patients more options for effective drug delivery. In conclusion, the demand for injectable drug delivery devices in the United States is propelled by the increasing prevalence of chronic diseases, the aging population, advancements in biotechnology, and the convenience these devices offer to patients. As healthcare continues to evolve, injectable drug delivery devices remain at the forefront, playing a vital role in the administration of therapeutic drugs and contributing to improved patient outcomes.

Report Attribute/Metric Details
Market Size 2022 USD 17.5 billion
Market Size 2023 USD 19.53 billion
Market Size 2030 USD 37.73 billion
Compound Annual Growth Rate (CAGR) 11.6% (2023-2030)
Base Year 2022
Market Forecast Period 2023-2030
Historical Data 2018 - 2021
Market Forecast Units Value (USD Billion)
Report Coverage Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends
Segments Covered Devices, Therapeutic Application, Site of Delivery and Region
Geographies Covered North America, Europe, Asia Pacific, and Rest of the World
Countries Covered The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil
Key Companies Profiled Eisai Co. Ltd, Antares Pharma, AstraZeneca, Becton, Dickinson and Company, Eli Lilly and Company.
Key Market Opportunities Growing awareness of vaccination in third-world countries
Key Market Dynamics Rapid increase in demand of medical equipment.


Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.